Financials disclosed in this offering
FY2023–FY2024 · hover for sourceThe fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Amendments to this offering
1 amendment- Apr 6, 2026No change to filed terms
“This amendment is being filed to clarify rolling closing procedures, including minimum incremental closing thresholds, and to update disclosures regarding financial statement requirements and investor dilution associated with SAFEs. No material changes.”
Form C/A on EDGAR ↗
Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.
Deal terms
No priced terms — this is a revenue-share or unpriced offering.
Offering details
Links & provenance
0002118074-26-000001
Last synced Aug 17, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.